Cardiff Oncology Inc (CRDF)
4.22
+0.05
(+1.20%)
USD |
NASDAQ |
Apr 24, 14:02
Cardiff Oncology Profit Margin (Quarterly): -5.99K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.99K% |
| September 30, 2023 | -6.90K% |
| June 30, 2023 | -10.32K% |
| March 31, 2023 | -13.52K% |
| December 31, 2022 | -6.79K% |
| September 30, 2022 | -9.22K% |
| June 30, 2022 | -11.48K% |
| March 31, 2022 | -14.86K% |
| December 31, 2021 | -7.10K% |
| September 30, 2021 | -8.04K% |
| June 30, 2021 | -9.94K% |
| March 31, 2021 | -7.19K% |
| December 31, 2020 | -5.54K% |
| September 30, 2020 | -3.31K% |
| June 30, 2020 | -9.59K% |
| March 31, 2020 | -6.01K% |
| December 31, 2019 | -4.58K% |
| September 30, 2019 | -8.01K% |
| June 30, 2019 | -10.76K% |
| March 31, 2019 | -6.30K% |
| December 31, 2018 | -5.33K% |
| September 30, 2018 | -4.27K% |
| June 30, 2018 | -3.35K% |
| March 31, 2018 | -4.78K% |
| December 31, 2017 | -1.39K% |
| Date | Value |
|---|---|
| September 30, 2017 | -3.48K% |
| June 30, 2017 | -7.89K% |
| March 31, 2017 | -10.52K% |
| December 31, 2016 | -12.56K% |
| September 30, 2016 | -11.44K% |
| June 30, 2016 | -9.87K% |
| March 31, 2016 | -8.52K% |
| December 31, 2015 | -9.32K% |
| September 30, 2015 | -4.77K% |
| June 30, 2015 | -17.39K% |
| March 31, 2015 | -5.65K% |
| December 31, 2014 | -8.30K% |
| September 30, 2014 | -9.40K% |
| June 30, 2014 | -1.94K% |
| March 31, 2014 | -2.87K% |
| December 31, 2013 | -2.17K% |
| September 30, 2013 | -10.06K% |
| June 30, 2013 | -10.76K% |
| March 31, 2013 | -932.4% |
| December 31, 2012 | -3.88K% |
| September 30, 2012 | -307.4% |
| June 30, 2012 | -8.26K% |
| March 31, 2012 | -3.40K% |
| December 31, 2011 | -3.70K% |
| September 30, 2011 | 16.85% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.86K%
Minimum
Mar 2022
-3.31K%
Maximum
Sep 2020
-8.38K%
Average
-8.01K%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
| BioVie Inc | -- |
| Perspective Therapeutics Inc | -- |
| Biolase Inc | -39.48% |
| Tenon Medical Inc | -387.9% |
| Adial Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.42% |
| Return on Assets | -42.26% |
| Return on Invested Capital | -47.42% |
| Operating Margin (Quarterly) | -6.62K% |
| Return on Net Operating Assets | -1.12K% |